Recombinant proteins expressed in plants have been emerged as a novel branch of the
biopharmaceutical industry, offering practical and safety advantages over traditional …

Plant represented the essence of pharmacopoeia until the beginning of the 19th century
when plant-derived pharmaceuticals were partly supplanted by drugs produced by the …

The expression of infectious bursal disease virus (IBDV) host‐protective immunogen VP2
protein in rice seeds, its immunogenicity and protective capability in chickens were …

During the past two decades, antibodies, antibody derivatives and vaccines have been
developed for therapeutic and diagnostic applications in human and veterinary medicine …

Numerous reviews have been published on infectious bursal disease (IBD) and infectious
bursal disease virus (IBDV). Many high quality vaccines are commercially available for the …

Since 2017, novel variant strains of infectious bursal disease virus (nvIBDV) have been
detected in China, while the current vaccines on the market against very virulent IBDV have …

We report here the in planta production of the recombinant vaccinia virus B5 antigenic
domain (pB5), an attractive component of a subunit vaccine against smallpox. The antigenic …

Plants have been studied for the production of pharmaceutical compounds for more than two
decades now. Ever since the plant‐made poultry vaccine against Newcastle disease virus …

Infectious Bursal Disease Virus (IBDV) is the etiological agent of an immunosuppressive and
highly contagious disease that affects young birds. This disease causes important economic …

This review examines the challenges of segregating biopharmed crops expressing
pharmaceutical or veterinary agents from mainstream crops, particularly those destined for …